GRANATA BIO Corp
Last verified 2026-05-05. JSON
| Total raised | $13.8M |
|---|---|
| Latest round | Funding round, $13.8M, 2024-12-19 |
| Founded | 2018 |
| Headquarters | Duxbury, MA |
| Industry | bio |
| Stage | unknown |
| Website | granata.bio |
Granata Bio identifies and develops fertility medications for the North American IVF market across ovarian stimulation, trigger shots, and luteal phase support. It serves US fertility clinics, IVF patients, and pharma partners looking for a specialist commercial channel. Leadership brings 130+ combined years in reproductive health regulatory and commercialization.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2024-12-19 | Funding round | $13.8M | undisclosed |
Detected tech stack
Typekit, Adobe Fonts, Afterpay, Sentry, Squarespace, Squarespace Commerce, Stimulus, web-vitals, moment 0, lodash ., @sentry/browser, React
Provenance
| Fact | Status | Basis |
|---|---|---|
| Funding round, $13.8M | sourced | SEC EDGAR named as publisher. Document, retrieved 2026-09-25. |
| Total raised $13.8M | sourced | SEC EDGAR named as publisher. Document, retrieved 2026-09-25. |
| Company existence | self-reported | granata.bio, read 2026-05-05 |
| Description | self-reported | granata.bio, read 2026-05-05 |
Change history
| Date | Fact | Change | Basis |
|---|---|---|---|
| 2026-09-25Latest round: seed, $13.8M, 2024-12-19 → Funding round, $13.8M, 2024-12-19, SEC EDGAR, document, retrieved 2026-09-25 | Latest round | seed, $13.8M, 2024-12-19 → Funding round, $13.8M, 2024-12-19 | SEC EDGAR, document, retrieved 2026-09-25 |
| 2026-09-25Round: attributed → sourced, SEC EDGAR, document, retrieved 2026-09-25 | Round | attributed → sourced | SEC EDGAR, document, retrieved 2026-09-25 |
Records begin 2026-09-24. All changes